AbbVieABBV · United States
Key figures.
Technical analysis.
Computed automatically from the last year of closing prices.
- Uptrend: the price is above its 50-day moving average (269.29 $), which is itself above the 200-day one (237.10 $).
- RSI at 73: overbought zone (above 70). It rose a lot, fast; a pause or pullback is possible, with no certainty.
- The price is at its 3-month high (294.89 $).
This is a reading of the past, not a forecast. Understand RSI and moving averages (in French) ›
What to know about AbbVie.
Sector: Healthcare
AbbVie is a US drugmaker known for Humira and for treatments in immunology and oncology.
Over one year, AbbVie shows +35.2 %. Its annualised volatility is around 25%, a moderate level, and its deepest drop from a peak over the period reached −16.5 %. The price sits +0.0 % from its 1-year high. These figures are computed automatically from daily closes: they describe the past and predict nothing.
Latest alerts on AbbVie.
- No recent alert on AbbVie. The radar posts one when the stock moves sharply during the day or suddenly.
Learn how the stock market works.
Simple guides, no jargon (in French).
Frequently asked questions.
What is the AbbVie stock price today?
The AbbVie stock (ABBV) is at 294.89 $ at 10:43 (Paris time), +1.41 % on the day. The market is closed, this is the last known price.
Where is AbbVie listed?
AbbVie is listed on a US exchange (Nasdaq or NYSE), in USD.
Are these prices real-time?
They come from Yahoo Finance and can be a few minutes late. They only move while the market is open.
What does AbbVie do?
AbbVie is a US drugmaker known for Humira and for treatments in immunology and oncology.
How volatile is AbbVie?
Over one year, AbbVie shows +35.2 %. Its annualised volatility is around 25%, a moderate level, and its deepest drop from a peak over the period reached −16.5 %. The price sits +0.0 % from its 1-year high. These figures are computed automatically from daily closes: they describe the past and predict nothing.
